A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune ...

Scientists have developed a strategy to boost the cancer-fighting power of natural killer (NK) cells, part of the immune system's first line of defense.

Researchers suppressed two inhibitory proteins using small-molecule drugs. The approach enhanced natural killer cell killing ...

ImmunityBio (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced the successful completion of manufacturing engineering programs, NK2022 and NK2023, establishing a safe, ...

Cancer immunotherapy has been transformed by engineered T cells, but those bespoke treatments are slow, expensive, and out of reach for many patients who need help quickly. A new way to generate vast ...

A unique and reliable approach for inducing NK cells from iPSCs (iNK) in a completely feeder-free environment was designed in this study. After 35 days, the cell proportion of CD3-CD56 + iNK Cells ...

Cha Biotech partners with Miltenyi Biotec to advance CAR-NK therapy in Korea German suppliers lentiviral vectors to power Cha ...

Weill Cornell Medicine researchers have identified that Hodgkin lymphoma cells are immune cells trapped midway between B cell and plasma cell development, unable to produce antibodies. This ...

For the first time, Weill Cornell Medicine researchers have demonstrated that Hodgkin lymphoma cancer cells from patient ...